chr18-657645-ACCGCGCCACTTGGCCTGCCTCCGTCCCG-A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

The NM_001071.4(TYMS):​c.-58_-31delGGCCTGCCTCCGTCCCGCCGCGCCACTT variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.304 in 997,140 control chromosomes in the GnomAD database, including 79,792 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.42 ( 13516 hom., cov: 0)
Exomes 𝑓: 0.28 ( 66276 hom. )

Consequence

TYMS
NM_001071.4 5_prime_UTR

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.424

Publications

51 publications found
Variant links:
Genes affected
TYMS (HGNC:12441): (thymidylate synthetase) Thymidylate synthase catalyzes the methylation of deoxyuridylate to deoxythymidylate using, 10-methylenetetrahydrofolate (methylene-THF) as a cofactor. This function maintains the dTMP (thymidine-5-prime monophosphate) pool critical for DNA replication and repair. The enzyme has been of interest as a target for cancer chemotherapeutic agents. It is considered to be the primary site of action for 5-fluorouracil, 5-fluoro-2-prime-deoxyuridine, and some folate analogs. Expression of this gene and that of a naturally occurring antisense transcript, mitochondrial enolase superfamily member 1 (GeneID:55556), vary inversely when cell-growth progresses from late-log to plateau phase. Polymorphisms in this gene may be associated with etiology of neoplasia, including breast cancer, and response to chemotherapy. [provided by RefSeq, Aug 2017]
TYMSOS (HGNC:29553): (TYMS opposite strand RNA)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.436 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TYMSNM_001071.4 linkc.-58_-31delGGCCTGCCTCCGTCCCGCCGCGCCACTT 5_prime_UTR_variant Exon 1 of 7 ENST00000323274.15 NP_001062.1 P04818-1Q53Y97
TYMSNM_001071.4 linkc.-97_-70delCCGCGCCACTTGGCCTGCCTCCGTCCCG upstream_gene_variant ENST00000323274.15 NP_001062.1 P04818-1Q53Y97

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TYMSENST00000323274.15 linkc.-97_-70delCCGCGCCACTTGGCCTGCCTCCGTCCCG 5_prime_UTR_variant Exon 1 of 7 1 NM_001071.4 ENSP00000315644.10 P04818-1
TYMSENST00000323274.15 linkc.-97_-70delCCGCGCCACTTGGCCTGCCTCCGTCCCG non_coding_transcript_variant 1 NM_001071.4 ENSP00000315644.10 P04818-1
TYMSENST00000323274.15 linkc.-97_-70delCCGCGCCACTTGGCCTGCCTCCGTCCCG upstream_gene_variant 1 NM_001071.4 ENSP00000315644.10 P04818-1

Frequencies

GnomAD3 genomes
AF:
0.415
AC:
61443
AN:
147948
Hom.:
13507
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.392
Gnomad AMI
AF:
0.556
Gnomad AMR
AF:
0.391
Gnomad ASJ
AF:
0.442
Gnomad EAS
AF:
0.158
Gnomad SAS
AF:
0.351
Gnomad FIN
AF:
0.513
Gnomad MID
AF:
0.403
Gnomad NFE
AF:
0.440
Gnomad OTH
AF:
0.422
GnomAD4 exome
AF:
0.284
AC:
241485
AN:
849088
Hom.:
66276
AF XY:
0.287
AC XY:
119801
AN XY:
416870
show subpopulations
African (AFR)
AF:
0.265
AC:
4294
AN:
16176
American (AMR)
AF:
0.361
AC:
2699
AN:
7472
Ashkenazi Jewish (ASJ)
AF:
0.346
AC:
4455
AN:
12872
East Asian (EAS)
AF:
0.147
AC:
3247
AN:
22036
South Asian (SAS)
AF:
0.211
AC:
5806
AN:
27550
European-Finnish (FIN)
AF:
0.469
AC:
11544
AN:
24610
Middle Eastern (MID)
AF:
0.281
AC:
711
AN:
2526
European-Non Finnish (NFE)
AF:
0.283
AC:
198045
AN:
700476
Other (OTH)
AF:
0.302
AC:
10684
AN:
35370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
4403
8806
13210
17613
22016
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4682
9364
14046
18728
23410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.415
AC:
61467
AN:
148052
Hom.:
13516
Cov.:
0
AF XY:
0.413
AC XY:
29839
AN XY:
72278
show subpopulations
African (AFR)
AF:
0.392
AC:
15612
AN:
39864
American (AMR)
AF:
0.391
AC:
5863
AN:
14988
Ashkenazi Jewish (ASJ)
AF:
0.442
AC:
1521
AN:
3442
East Asian (EAS)
AF:
0.158
AC:
789
AN:
5000
South Asian (SAS)
AF:
0.352
AC:
1650
AN:
4692
European-Finnish (FIN)
AF:
0.513
AC:
5243
AN:
10228
Middle Eastern (MID)
AF:
0.413
AC:
119
AN:
288
European-Non Finnish (NFE)
AF:
0.440
AC:
29329
AN:
66624
Other (OTH)
AF:
0.416
AC:
848
AN:
2040
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
1609
3218
4826
6435
8044
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
566
1132
1698
2264
2830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.249
Hom.:
531

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.42
Mutation Taster
=299/1
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45445694; hg19: chr18-657645; COSMIC: COSV60074424; COSMIC: COSV60074424; API